Arca
Skip to content
Tools
Tools

DRD2: D(2) dopamine receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

G protein-coupled receptor for dopamine, a catecholamine neurotransmitter hormone that functions as the brain's 'reward chemical', driving motivation, reinforcement learning and pleasure.

  • Drugs that act on it: 61
  • Approved: 42
  • In phases 1 to 3: 19
  • Sponsors: 35

Who Is On It, and How Far Along

Every drug ChEMBL records acting on DRD2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule
  • Other

Approved42

Phase 38

Phase 211

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    Modalities

    Drugs on this target by ChEMBL molecule type.

    • Small molecule6098%
    • Other12%

    The Landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 44 of 61 act as: Dopamine D2 receptor antagonist; the rest name their own mechanism.
    AripiprazoleApprovedOtsuka PharmaceuticalSmall moleculePartial agonistDopamine D2 receptor partial agonist36Boxed warning
    RisperidoneApprovedJohnson & JohnsonSmall moleculeAntagonist—29Boxed warning
    QuetiapineApprovedCheplapharmSmall moleculeAntagonist—28Boxed warning
    ClozapineApprovedHeritage LifeSmall moleculeAntagonist—24Boxed warning
    MetoclopramideApprovedANI PharmaceuticalsSmall moleculeAntagonist—20Boxed warning
    LumateperoneApprovedIntra-Cellular TherapiesSmall moleculeAntagonist—15Boxed warning
    CabergolineApprovedPfizerSmall moleculeAgonistDopamine D2 receptor agonist14—
    BrexpiprazoleApprovedOtsuka PharmaceuticalSmall moleculePartial agonistDopamine D2 receptor partial agonist12Boxed warning
    CariprazineApprovedAbbVieSmall moleculeModulatorDopamine D2 receptor modulator12Boxed warning
    DomperidoneApprovedEisaiSmall moleculeAntagonist—8—
    LurasidoneApprovedSumitomo PharmaSmall moleculeAntagonist—8Boxed warning
    PaliperidoneApprovedJohnson & JohnsonSmall moleculeAntagonist—7Boxed warning
    Paliperidone palmitateApprovedJohnson & JohnsonSmall moleculeAntagonist—5Boxed warning
    ProchlorperazineApprovedSignPath Pharma, Inc.Small moleculeAntagonist—4Boxed warning
    IloperidoneApprovedVanda PharmaceuticalsSmall moleculeAntagonist—3Boxed warning
    ZiprasidoneApproved—Small moleculeAntagonist—3Boxed warning
    ThiethylperazineApprovedImmungenetics AGSmall moleculeAntagonist—2—
    Aripiprazole lauroxilApprovedAlkermesSmall moleculePartial agonistDopamine D2 receptor partial agonist1Boxed warning
    AsenapineApprovedOrganonSmall moleculeAntagonist—1Boxed warning
    ChlorprothixeneApprovedRocheSmall moleculeAntagonist—1—
    FluspirileneApproved—Small moleculeInhibitorDopamine D2 receptor inhibitor1—
    PerphenazineApprovedMerck & Co. (MSD)Small moleculeAntagonist—1Boxed warning
    SulpirideApproved—Small moleculeAntagonist—1—
    TrimipramineApprovedTeva Pharmaceutical IndustriesSmall moleculeAntagonist—1Boxed warning
    AcetophenazineApprovedMerck & Co. (MSD)Small moleculeAntagonist—0—
    BenperidolApproved—Small moleculeAntagonist—0—
    BenzquinamideApprovedPfizerSmall moleculeModulatorDopamine D2 receptor modulator0—
    BlonanserinApprovedMarubeni Pharmaceuticals (Suzhou) Co., Ltd.Small moleculeAntagonist—0—
    BromperidolApproved—Small moleculeAntagonist—0—
    CarphenazineApprovedPfizerSmall moleculeAntagonist—0—
    FluphenazineApprovedBristol-Myers SquibbSmall moleculeAntagonist—0Boxed warning
    Fluphenazine decanoateApprovedBristol-Myers SquibbSmall moleculeAntagonist—0Boxed warning
    Fluphenazine enanthateApprovedBristol-Myers SquibbSmall moleculeAntagonist—0—
    MesoridazineApprovedNovartis PharmaceuticalsSmall moleculeAntagonist—0Boxed warning
    MolindoneApprovedChartwell RXSmall moleculeAntagonist—0Boxed warning
    PiperacetazineApprovedDow PharmSmall moleculeAntagonist—0—
    QuinagolideApprovedFerring PharmaceuticalsSmall moleculeAgonistDopamine D2 receptor agonist0—
    RemoxiprideApproved—Small moleculeAntagonist—0Withdrawn
    SertindoleApprovedH. Lundbeck A/SSmall moleculeAntagonist—0Withdrawn
    ThiothixeneApproved—Small moleculeAntagonist—0Boxed warning
    TriflupromazineApproved—Small moleculeAntagonist—0—
    VeraliprideApproved—Small moleculeAntagonist—0Withdrawn
    ItopridePhase 3Getz PharmaSmall moleculeAntagonist—6—
    PridopidinePhase 3PrileniaSmall moleculeModulatorDopamine D2 receptor modulator3—
    AlizapridePhase 3—Small moleculeAntagonist—0—
    BifeprunoxPhase 3H. Lundbeck A/SSmall moleculePartial agonistDopamine D2 receptor partial agonist0—
    BromopridePhase 3EMSSmall moleculeAntagonist—0—
    SarizotanPhase 3Merck KGaASmall moleculePartial agonistDopamine D2 receptor partial agonist0—
    SumanirolePhase 3PfizerSmall moleculeAgonistDopamine D2 receptor agonist0—
    TiapridePhase 3Tasly Pharmaceuticals, Inc.Small moleculeAntagonist—0—
    LevosulpiridePhase 2—Small moleculeAntagonist—1—
    AdoprazinePhase 2—Small moleculeAntagonist—0—
    AplindorePhase 2Neurogen CorporationSmall moleculePartial agonistDopamine D2 receptor partial agonist0—
    ClebopridePhase 2—Small moleculeAntagonist—0—
    JNJ-37822681Phase 2Johnson & JohnsonSmall moleculeAntagonist—0—
    OnzigolidePhase 2Tiburio TherapeuticsOtherAgonistDopamine D2 receptor agonist0—
    OrdopidinePhase 2NeuroSearch A/SSmall moleculeModulatorDopamine D2 receptor modulator0—
    PF-00217830Phase 2PfizerSmall moleculePartial agonistDopamine D2 receptor partial agonist0—
    SB-773812Phase 2GSKSmall moleculeAntagonist—0—
    SeridopidinePhase 2—Small moleculeModulatorDopamine D2 receptor modulator0—
    TrazpirobenPhase 2Takeda Pharmaceuticals USASmall moleculeAntagonist—0—

    Open Trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 109 in all, from ClinicalTrials.gov.
    Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With SchizophreniaPaliperidone, Paliperidone palmitatePhase 4Not yet recruitingAlejandro Alva2026-11-10
    Sequential Treatment Approaches for Treatment-Resistant SchizophreniaAripiprazole, ClozapinePhase 3RecruitingShanghai Mental Health Center2026-11-05
    Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese AdultsAripiprazolePhase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.2026-11-03
    Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective DisorderAripiprazole, Quetiapine—RecruitingBosnalijek D.D2026-10-05
    Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional BluntingLumateperonePhase 4Not yet recruitingFuture Options Research, LLC2026-09-17
    Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side EffectsClozapineNot applicableRecruitingFaculty of Medicine, Sousse2026-09-14
    The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.AripiprazolePhase 2Not yet recruitingWashington University School of Medicine2026-09-09
    Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderLurasidonePhase 4Not yet recruitingMartin Lan2026-09-08
    Discontinuing Psychotropic Medication Before Psychotherapy for PTSDQuetiapine—Not yet recruitingAcademic Centre for Dentistry in Amsterdam2026-09-03
    Caplyta Versus Placebo for Adults With Social Anxiety DisorderLumateperonePhase 4RecruitingJason Careri2026-09-02
    Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101LurasidoneEarly phase 1RecruitingMclean Hospital2026-08-25
    Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyLurasidonePhase 3Not yet recruitingBukwang Pharmaceutical2026-08-24
    Study of rTMS in Maintenance in Treatment Resistant DepressionQuetiapinePhase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar2026-08-12
    A Study of Lumateperone Versus Placebo in Participants With Major Depressive DisorderLumateperonePhase 3Not yet recruitingIntra-Cellular Therapies, Inc.2026-08-05
    A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With SchizophreniaBrexpiprazolePhase 2 / Phase 3Not yet recruitingBostal Drug Delivery Co., Ltd2026-08-03
    Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal AnesthesiaMetoclopramidePhase 4RecruitingSanliurfa Education and Research Hospital2026-07-31
    Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency DisorderLumateperonePhase 2RecruitingCSTrials Inc.2026-07-29
    A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and CabergolineCabergolinePhase 1Not yet recruitingYanping Kong2026-07-28
    Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA TrialItoprideNot applicableRecruitingAsian Institute of Gastroenterology, India2026-07-28
    Single-case Intervention Study for Visual Screening Assessment for Proof of Concept and Prediction of Clinical Response to Brexiprazole as Adjunctive Treatment in Adults With Major Depressive Disorder.BrexpiprazoleNot applicableActive, not recruitingUniversity of Sao Paulo2026-07-23
    A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With SchizophreniaCariprazinePhase 2 / Phase 3Not yet recruitingBostal Drug Delivery Co., Ltd2026-07-23
    ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's DiseaseClozapinePhase 1Not yet recruitingQianfoshan Hospital2026-07-22
    Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)AripiprazolePhase 2Not yet recruitingChristiana Franke2026-07-20
    Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaBrexpiprazole, CariprazinePhase 1Not yet recruitingNew York State Psychiatric Institute2026-07-20
    Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia AdultsAripiprazolePhase 2Not yet recruitingVigonvita Life Sciences2026-07-15
    MicroRNAs as Biomarkers in First Episode SchizophreniaAripiprazole, RisperidoneNot applicableRecruitingNorthwell Health2026-07-14
    The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar DepressionLumateperonePhase 4RecruitingMassachusetts General Hospital2026-07-13
    This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse EffectsCariprazine, LumateperonePhase 4Not yet recruitingWatim Medical & Dental College2026-06-30
    Risperidone vs Cariprazine in Acute ManiaCariprazine, RisperidonePhase 4Not yet recruitingPakistan Institute of Medical Sciences2026-06-24
    Efficacy and Mechanism of IPSRT for Bipolar II DisorderQuetiapinePhase 2Not yet recruitingFirst Affiliated Hospital of Zhejiang University2026-06-17
    Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic CholecystectomyMetoclopramidePhase 4RecruitingFaisalabad Medical University2026-06-10
    Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion TreatmentMetoclopramidePhase 4Not yet recruitingMontefiore Medical Center2026-06-08
    Lumateperone for Late-Life DepressionLumateperonePhase 3RecruitingEric Lenze2026-06-03
    Postoperative GI Dysfunction and Nutrition in Malnourished Cancer Surgery PatientsMetoclopramide—Not yet recruitingArma Ltd.2026-06-03
    A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and RelapseQuetiapine—RecruitingThe University of Hong Kong2026-06-01
    Pridopidine Phase 3 Study in Huntington's DiseasePridopidinePhase 3RecruitingPrilenia2026-05-27
    No Guts No Glory ProbioticsClozapine, Quetiapine, RisperidonePhase 2 / Phase 3RecruitingUniversity Medical Center Groningen2026-05-26
    Combination Osilodrostat and Cabergoline in Cushing's DiseaseCabergolinePhase 4Enrolling by invitationUniversity of Basrah2026-05-22
    Dexamethasone Plus Metoclopramide Versus Paracetamol/NSAIDs for Primary HeadacheMetoclopramidePhase 4Not yet recruitingPak Emirates Military Hospital2026-05-22
    Effect of Digestive Enzymes as Add on Therapy on Patients With Functional Dyspepsia.DomperidonePhase 4Not yet recruitingRakibul Mostafa2026-05-11
    Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment AreaAripiprazole, Quetiapine, RisperidoneNot applicableNot yet recruitingUniversity of Alabama at Birmingham2026-05-06
    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesCabergolineNot applicableEnrolling by invitationEnhanced Emirates Limited2026-05-06
    Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRisperidonePhase 3RecruitingMinerva Neurosciences2026-05-04
    Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic NucleusClozapineEarly phase 1Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2026-04-16
    Shortened LSD Intervention for Major Depressive DisorderRisperidonePhase 1Not yet recruitingJohns Hopkins University2026-03-31
    Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast SymptomsCabergolinePhase 2RecruitingJefferson Drapkin2026-03-25
    A Bioequivalence Study of PP3M in Patients With SchizophreniaPaliperidone, Paliperidone palmitateNot applicableRecruitingCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.2026-03-25
    Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic EffectsRisperidonePhase 1RecruitingMedical University of Vienna2026-03-24
    Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With SchizophreniaCariprazinePhase 1RecruitingAnxo Pharmaceutical Co., Ltd.2026-03-20
    Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseRisperidonePhase 4RecruitingNorthwell Health2026-03-19
    Safety and Potency of a High Cabergoline Dosage in MicroprolactinomasCabergolinePhase 3RecruitingUniversity of Sao Paulo General Hospital2026-03-11
    Comparing Acotiamide and Itopride for the Management of IndigestionItopridePhase 4Not yet recruitingAga Khan University2026-03-04
    Standardized Sleep Bundle for Cardiac Surgery PatientsQuetiapineNot applicableRecruitingHorizon Health Network2026-02-11
    Carbergoline for Antipsychotic Induced Hyperprolactinemia.CabergolinePhase 4Not yet recruitingZealand University Hospital2026-02-04
    Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life AbuseLumateperonePhase 4Not yet recruitingUniversity of Texas at Austin2026-01-27
    Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic CholecystectomyMetoclopramidePhase 4Not yet recruitingAssiut University2026-01-22
    IV Injection of Metoclopramide With or Without DexamethasoneMetoclopramideEarly phase 1Not yet recruitingAhmed Nassar Ibrahim Mohammed2026-01-15
    Stratification and Treatment in Early Psychosis Study -ASSISTClozapinePhase 3Not yet recruitingUniversity of Oxford2026-01-08
    Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPridopidinePhase 3RecruitingPrilenia2026-01-07
    RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)CariprazinePhase 4RecruitingMayo Clinic2025-12-05
    Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialTrimipraminePhase 2RecruitingCentre Hospitalier Universitaire Vaudois2025-12-04
    Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOSCabergolineNot applicableRecruitingMst.Sumyara Khatun2025-12-01
    A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS TrialLurasidonePhase 2 / Phase 3RecruitingNeuroRx, Inc.2025-11-12
    Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and VomitingMetoclopramidePhase 3RecruitingAffiliated Hospital of Qinghai University2025-10-06
    Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral CariprazineCariprazinePhase 1 / Phase 2RecruitingMapi Pharma Ltd.2025-09-22
    Acotiamide vs Itopride in Postprandial Distress SyndromeItopridePhase 3Not yet recruitingGetz Pharma2025-09-15
    Postprandial Distress Itopride Cohort TrialItopride—Not yet recruitingUniversitaire Ziekenhuizen KU Leuven2025-09-10
    Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh StudyPaliperidonePhase 4Not yet recruitingSher-E-Bangla Medical College2025-09-04
    A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsCabergolinePhase 3RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.2025-08-15
    MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderFluspirilenePhase 2 / Phase 3RecruitingVA Office of Research and Development2025-08-12
    Domperidone and the Risk of Serious Adverse EventsDomperidone—Active, not recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2025-08-01
    Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionIloperidonePhase 2RecruitingVanda Pharmaceuticals2025-07-29
    A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's DiseaseClozapineEarly phase 1Not yet recruitingRuijin Hospital2025-07-25
    Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve GastrectomyThiethylperazineNot applicableNot yet recruitingIVO JURISIC2025-07-24
    Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in SchizophreniaPaliperidone, Paliperidone palmitatePhase 4Not yet recruitingJiangsu Province Nanjing Brain Hospital2025-07-20
    Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.Clozapine, Paliperidone, Paliperidone palmitate, AsenapinePhase 4Active, not recruitingDr. Stavroula Rakitzi2025-07-02
    Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual VolumeItopridePhase 4Not yet recruitingChulalongkorn University2025-06-22
    Randomized Withdrawal Study in Patients With SchizophreniaIloperidonePhase 3RecruitingVanda Pharmaceuticals2025-05-08
    Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of MigrainesProchlorperazinePhase 3RecruitingWake Forest University Health Sciences2025-04-01
    REXULTI General Use Results Survey in Patients With Hyperactivity, or Aggressive Behavior Associated With Alzheimer's DementiaBrexpiprazole—RecruitingOtsuka Pharmaceutical Co., Ltd.2025-03-14
    Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy AnalyzerDomperidone—Enrolling by invitationCentro Hospitalar de Lisboa Central2025-02-17
    Effects of Lurasidone on Left Ventricle Systolic FunctionsLurasidone—Not yet recruitingAydin Adnan Menderes University2024-11-19
    Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)DomperidonePhase 3Not yet recruitingUniversity Hospital, Rouen2024-11-19
    The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.BrexpiprazolePhase 1RecruitingSichuan Kelun Pharmaceutical Co.,Ltd.2024-11-05
    Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia RelapsesPaliperidoneNot applicableRecruitingCentre Hospitalier St Anne2024-09-25
    Precision Care for Major Depressive DisorderBrexpiprazolePhase 4Enrolling by invitationUniversity of California, San Francisco2024-08-30
    Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.ZiprasidonePhase 3RecruitingLouisiana State University Health Sciences Center Shreveport2024-07-01
    Sequential Multiple Assignment Randomized Trial for Bipolar DepressionCariprazine, LurasidonePhase 4Active, not recruitingMassachusetts General Hospital2024-05-30
    Maternal And Infant Antipsychotic StudyLurasidone, Ziprasidone—RecruitingIcahn School of Medicine at Mount Sinai2023-09-22
    Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive DisordersBrexpiprazole—RecruitingDr. Albert Kar-Kin Chung2023-07-27
    Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyProchlorperazinePhase 3RecruitingProton Collaborative Group2023-05-12
    Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade GliomasProchlorperazinePhase 1 / Phase 2RecruitingSignPath Pharma, Inc.2023-03-15
    REALITY MONITORING AND DOPAMINEDomperidone, SulpirideNot applicableRecruitingHôpital le Vinatier2023-02-02
    Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsIloperidonePhase 4RecruitingVanda Pharmaceuticals2022-12-13
    Chinese Longitudinal and Systematic Study of Bioplar DisorderLurasidoneNot applicableRecruitingFirst Affiliated Hospital of Zhejiang University2022-07-29
    Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaBrexpiprazolePhase 3RecruitingOtsuka Pharmaceutical Co., Ltd.2022-04-13
    5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCCProchlorperazinePhase 2RecruitingBarbara Burtness2022-04-07
    Apomorphine in Severe Brain-injured PatientsDomperidonePhase 2 / Phase 3RecruitingUniversity of Liege2022-01-28
    Compassionate Use of Domperidone for Refractory GastroparesisDomperidoneNot applicableRecruitingJose Cocjin2021-01-07
    "Extended" (Alternate Day) Antipsychotic DosingPaliperidone, Paliperidone palmitatePhase 4RecruitingCentre for Addiction and Mental Health2020-07-21
    HEALEY ALS Platform Trial - Master ProtocolPridopidinePhase 2 / Phase 3Active, not recruitingMerit E. Cudkowicz, MD2020-03-05
    Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial PeritonitisItopridePhase 3RecruitingTanta University2019-11-13
    Tick-borne Encephalitis and Borrelial Antibodies in SerumThiethylperazineNot applicableRecruitingUniversity Medical Centre Ljubljana2019-05-20
    Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaZiprasidonePhase 1Active, not recruitingUniversity of Arizona2018-12-19
    Bariatric Surgery and Pharmacokinetics of ChlorprothixeneChlorprothixene—RecruitingNorwegian University of Science and Technology2018-02-28
    Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular EdemaLevosulpiridePhase 2RecruitingCarmen Clapp2017-05-22
    Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CTPerphenazinePhase 1 / Phase 2Active, not recruitingUniversity of Pennsylvania2016-06-28
    Domperidone in Treating Patients With Gastrointestinal DisordersDomperidonePhase 3Active, not recruitingM.D. Anderson Cancer Center2012-10-01
    National Pregnancy Registry for Psychiatric MedicationsAripiprazole lauroxil—RecruitingMassachusetts General Hospital2010-11-23

    Diseases Most Associated With It

    Open Targets association score, 0 to 1; all associations
    Tourette syndrome
    0.65
    Parkinson disease
    0.63
    Autism
    0.63
    Psychotic disorder
    0.62
    Mental disorder
    0.61
    Bipolar I disorder
    0.60
    Agitation
    0.60

    Genes and Related Targets

    Complexes and families that share a gene with this target
    Genes
    DRD2

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL217, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P14416, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

    Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.